Is Ginkgo biloba + Glucosamine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 3 valid registrations of Ginkgo biloba + Glucosamine, including Cartiflex (500,50 mg,mg, Capsule, hard, SAR 26.00); DOROFEN 500-50 MG CAPSULE (500,50 mg,mg, Capsule, SAR 36.40).

Active substances

Ginkgo biloba + Glucosamine

SFDA 3

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Cartiflex	500,50 mg,mg	Capsule, hard · Oral use	40 Blister	SAR 26.00	Generic · OTC	Jamjoom Pharmaceuticals Factory Company	Valid
DOROFEN 500-50 MG CAPSULE	500,50 mg,mg	Capsule · Oral use	40 Blister	SAR 36.40	NCE · Prescription	LIPTIS PHARMACEUTICALS	Valid
DOROFEN 500-50 MG CAPSULE	500,50 mg,mg	Capsule · Oral use	90 Blister	SAR 81.90	Generic · Prescription	LIPTIS PHARMACEUTICALS	Valid

Components

Glucosamine

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.